Lantheus Holdings (LNTH) EBT Margin (2014 - 2026)

Lantheus Holdings (LNTH) reported EBT Margin of 41.45% for Q1 2026, up 1555.0% year-over-year from 2.5% in Q1 2025, and up 139.63% quarter-over-quarter from 17.3% in Q4 2025.

Lantheus Holdings (LNTH) EBT Margin (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of EBT Margin data on file, last reported at 41.45% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 41.45%, up 1555.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 24.17% (up 106.0% YoY), and the FY2025 annual result was 20.35%, down 767.0% from the prior year.
  • EBT Margin climbed to 41.45% in Q1 2026 per LNTH's latest filing, from 17.3% in the prior quarter.
  • Over five years, EBT Margin peaked at 922.69% in Q4 2023 and troughed at 66.97% in Q4 2022.
  • A 5-year average of 74.57% and a median of 27.72% in 2022 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2023 and 2024: EBT Margin surged 98966 bps in 2023, then plunged 92316 bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 66.97% in 2022, then soared by 1478 bps to 922.69% in 2023, then sank by 100 bps to 0.48% in 2024, then soared by 3735 bps to 17.3% in 2025, then jumped by 140 bps to 41.45% in 2026.
  • Business Quant data shows LNTH's EBT Margin at 41.45% in Q1 2026, 17.3% in Q4 2025, and 11.04% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 10.97%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 33.51%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 40.73%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 25.87%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 30.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.35%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -156.77%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 41.45%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.70%
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 42.74%

Historic Data

Download Data
DateValue
Mar 31, 2026 41.45%
Dec 31, 2025 17.30%
Sep 30, 2025 11.04%
Jun 30, 2025 27.65%
Mar 31, 2025 25.90%
Dec 31, 2024 -0.48%
Sep 30, 2024 46.50%
Jun 30, 2024 21.41%
Mar 31, 2024 46.29%
Dec 31, 2023 922.69%
Sep 30, 2023 49.99%
Jun 30, 2023 38.45%
Mar 31, 2023 -3.69%
Dec 31, 2022 -66.97%
Sep 30, 2022 34.69%
Jun 30, 2022 27.73%
Mar 31, 2022 27.72%
Dec 31, 2021 -31.65%
Sep 30, 2021 -19.43%
Jun 30, 2021 -28.24%